The Department of Pharmaceuticals (DoP) has invited comments from stakeholders on proposals received for amendments to the Global Tender Enquiry (GTE) Exemption List of Medical Devices.

The move follows a public notice issued on 11 February 2026 seeking feedback on the existing GTE Exemption List. In response, the Department received representations from various stakeholders requesting the addition, deletion, and modification of entries under the list.

According to the Department, the proposed changes are currently under consideration, and stakeholder feedback has been sought before a final decision is taken.

All concerned stakeholders, including domestic medical device manufacturers, importers, industry associations, procurement agencies, and healthcare institutions, have been requested to submit their comments along with supporting information by 15 July 2026.

The comments may be submitted via email to usmedicaldevices@pharma-dept.gov.in, with a copy marked to so-medicaldevices@pharma-dept.gov.in.

The GTE exemption mechanism is aimed at promoting domestic manufacturing by restricting global tender enquiries for specified medical devices where adequate indigenous manufacturing capacity exists. Periodic reviews of the exemption list are undertaken to ensure alignment with evolving industry capabilities and healthcare procurement requirements.

The Department has urged stakeholders to provide detailed inputs to facilitate an informed assessment of the proposed amendments.